J Korean Ophthalmol Soc > Volume 57(6); 2016 > Article
Journal of the Korean Ophthalmological Society 2016;57(6):1018-1021.
DOI: https://doi.org/10.3341/jkos.2016.57.6.1018    Published online June 15, 2016.
Noninfectious Endophthalmitis after Intravitreal Injection of Aflibercept.
Chung Hwan Kim, Ji Soo Shin, Chan Yang Jeon, Young Suk Chang, Young Hoon Lee
Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea. astrix001@kyuh.ac.kr
아플리버셉트 주사 후 발생한 비감염성 안내염
건양대학교 의과대학 안과학교실
Correspondence:  Young Hoon Lee,
Email: astrix001@kyuh.ac.kr
Received: 1 October 2015   • Revised: 31 December 2015   • Accepted: 25 February 2016
To report a case of noninfectious endophthalmitis after intravitreal injection of aflibercept. CASE SUMMARY: A 67-year-old male patient presented with sudden vision loss 2 days after intravitreal aflibercept injection for neovascular age-related macular degeneration. Mild conjunctival injection and moderate inflammation in the anterior chamber were noted, but he had no ocular pain or hypopyon. The patient was diagnosed with noninfectious endophthalmitis and successfully treated with topical antibiotics and topical steroid eye drops. The infection was apparently cleared at 3 days. At 10 days after the initial presentation, his vision loss resolved completely. CONCLUSIONS: Noninfectious endophthalmitis after intravitreal injection of aflibercept can be treated with topical steroids.
Key Words: Intravitreal aflibercept injection;Noninfectious endophthalmitis

Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2022 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next